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The dimensions of  the  specific  combining regions of  the antibody molecule (i.e., 
the combining sites) is of fundamental importance for an understanding of the mecha- 
nisms of antibody-antigen interaction, and the biological effects of these interactions. 
The work of Kabat (1) which utilized quantitative hapten inhibition methods, indi- 
cates  that  human anti-dextran antibody combining sites  are  sufficiently large  to 
encompass an antigenic unit the size of a hexasaccharide. Similarly, Cebra's studies (2) 
indicates that rabbit anti-silk fibroin antibody-combining  sites are complementary to 
an antigenic unit at ]east the size of an octapeptide or a dodecapeptide. Several other 
works which examined rabbit anti-hapten antibodies by quantitative precipitation 
methods indicated that at least some of the anti-hapten antibody molecules possessed 
combining sites complementary to an antigenic unit comprised of hapten and adjoin- 
ing carrier protein structures. (Haurowitz, p-azoarsanilic acid (3) ; Eisen et al., dinitro- 
phenyl (4) ; and Buchanan-Davidson et al.,  synthetic polypeptides (5)). 
In  sharp  contrast  to  these  findings, Landsteiner and  van der  Scheer  (6)  using 
qualitative absorption and precipitation methods, concluded that rabbit antibodies 
to an azostroma in which the hapten consisted of an arsanilic acid group and a suc- 
cinanilic acid group attached to the same benzene ring, (i.e. a bifunctional hapten, Fig. 
1,  SA hapten)  were  complementary to one group or  the other,  but were  not com- 
plementary to  the entire bifunctional hapten. They obtained similar results with a 
second  bifunctional hapten,  azoisophthalyl-glycine-leucine (Fig.  1,  GIL  hapten). 
These results would indicate that, at least for these systems, the antibody-combining 
sites were not sufficiently large to encompass the entire bifunctional hapten molecule. 
Recently, the benzylpenicilloyl-lysine  haptenic group  (Fig.  1)  which results from 
the  reaction of  D-benzylpenicillenic acid  with  lysine e-NH2 groups  of  protein, has 
become  available for  study  (7).  The  BPO-lysine' group  is  a  comparatively large 
* Presented in part before the American Association of Immunologists, Atlantic City, New 
Jersey, April, 1962. (Fed. Proc. 1962, 21, 32.) 
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1  Abbreviations: BPO, benzylpenicilloyl group; AMMPO,  allylmercaptomethylpenicilloyl 
group; DMPPO, dimethoxyphenylpenicilloyl group; PAC, phenylacetylamine group  Proteins 
are abbreviated: HGG, human "g-globulin;  HSA, human  serum albumin; RGG, rabbit 3'-globu- 
161 Fro.  1. Structural formulas and photographs of Fisher-Hirschfelder Taylor scale molecular 
models of several bifunctional haptenic groups,  i  cm.  =  1 A, A, SA haptenie group; B, BPO 
group; C, DMPPO grouo; D, AMMPO group; and E, GIL group. The SA and  GIL haptenic 
groups are shown coupled to tyrosine residues of protein; the Denicilloyl haptenic groups are 
shown coupled  to  lysine e-NIt~  residues of protein.  The  BPO  group  is  shown  divided  by 
brackets  into  the  phenylacetylamine part  (left)  and  the  thiazolidine  carboxylic  acid  part 
(right). 
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haptenic group, intermediate in size between the two bifunctional haptens  used by 
Landsteiner  (Fig.  1). The BPO group also may be considered a  bifunctional hapten 
comprised of a  non-polar phenylacetylamine end and a polar thiazolidine carboxylic 
acid end  (Fig.  1). The BPO group is of additional interest since it has been demon- 
strated  to  be  the  major  antigenic  determinant  responsible  for hypersensitivity  to 
benzylpenic~llln in human beings and in experimental animals (7, 8). 
In the present  work rabbit  andsera  prepared  against  the  BPO-lysine  hap- 
tenic group were examined to determine whether anti-BPO antibody-combining 
sites  are  adapted  to  only  the  phenylacetylamine  end  or  to  the  thiazolidine 
carboxylic  acid  end  of  the  BPO  molecule,  or  whether  the  combining  sites 
encompass the entire BPO haptenic group. Also investigated was the extent to 
which anti-BPO  antibody combining sites are directed against the lysine side 
chain (through which the BPO groups are bound predominantly to the protein 
carrier),  and whether  the anti-BPO combining sites are adapted also to struc- 
tural areas of the carrier protein. 
The results  obtained  demonstrate  that at least a  large part of rabbit anti- 
BPO antibodies are specifically adapted  to an antigenic unit comprised of the 
entire  BPO  group,  the  lysine  side  chain,  and  structfiral  areas  (probably  ad- 
joining  the  point  of  attachment  of  the  hapten)  of  the  carrier  protein.  No 
antibodies which encompass only the phenylacetylamine end or the thiazolidine 
carboxylic acid end of the BPO molecule were detected in the rabbit anti-BPO 
sera. 
Matcr/a/s.--Crystalline potassium benzylpenicillin  (Lot F-0079)  and sodium dimethoxy- 
phenylpenicillin  (staphcillin,  Lot A-1028) were donated by Bristol Laboratories,  ~ Syracuse, 
New York. Crystalline sodium allylmercaptomethylpenicillin  (Cer-O-Cillin,  Lot  MM-344) 
was donated by the Upjohn Co.,  2 Kalamazoo, and crystalline sodium  benzylpenlcillin  was 
donated by Pfizer Laboratories,  2 Brooklyn. Other chemicals were of reagent grade. Complete 
Freund's adjuvant was a product of Difco Laboratories, Detroit. 
Poly-r--Lysine.HC1  with an average chain  length of 20 units  (manufacturer's analysis, 
Lot 02202) was donated by the Kremers-Urban Co.,  Milwaukee. Human serum albumin, and 
human "/-globniln were gifts of the American Red Cress.  RSA  I was prepared from pooled 
normal rabbit serum by ammonium stflfate  fractionatlon.  RSA was purified  further by a 
method similar to the trichloracetlc  acid method described by Schwert for bovine serum al- 
bumin (9), which is reported to result in llttle or no protein denaturation (9, 10). By paper 
lin; RSA, rabbit serum alb~min; PLL, poly-z.lysine. Conjugates are abbreviated: BPO~-HGG, 
DMPP(h¢-RSA etc. for benzylpenicRloyl- human "y-globulin and dimethoxyphenylpenlcilloyl- 
rabbit serum albl]mln~ Subscript numbers refer to the average number of haptenic groups per 
molecule of conjugate. Univalent penicilloyl amine haptens are abbreviated: BPO-EACA, for 
benzylpenicilloyl-e-aminocaproate;  DMPPO-~-propy|amine for dimethoxyphenylpenlcilloyl- 
n-propylamine etc. B.S., buffered saline, 0.15 ~ sodium chloride, 0.02 ~ phosphate. 
We thank Drs. J. Doyle of Bristol Laboratories., J. O. Lawrence of Upjohn Co.,  W. 
Fuhrman of Pfizer Labs., B. Lees of Kremers-Urban Co., and J. H. Pert of the American Red 
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electmphoresis and by immunoelectrophoresis,  3 the material was pure except for a  trace of 
a2-globuliu.  Protein  contents of  these preparations were  determined by  duplicate  micro- 
Kjeldahl (11 a) analyses. 
Ultraviolet absorption studies were done with a  Zeiss model PMQ 11 spectrophotometer 
and 1 cm light path matched quartz cuvettes. Optical rotations were taken with a  Schmidt 
and Haensch polarimeter using a 2 decimeter cell. 
Penicillen~ Ac/ds.--~-Benzylpenicillenic  acid was prepared by method described previously 
(12):  ~  =  24,000 at k,=~x 322  nag.  D-Allylmercaptomethylpenicillenic acid  was  prepared 
from  sodium  allylmercaptomethylpenicillenic by  the method used  for D-benzylpenicillenic 
acid; k  ma~ 328 m#, ~ --=  11,000,  4 (95 per cent ethanol). D-Dimethoxyphenylpenicillenic acid 
was prepared as follows:  5 To a solution of 7.0 gin. (16.7 mmoles) of sodium dimethoxyphenyl- 
penicillin and 4.55 gin. (20.2 mmoles) mercuric chloride in 250 ml water at room temperature, 
was added dropwise with stirring 16.7 ml of 1.0 N HC1. 4 Stirring was continued for 1 hour. The 
precipitated yellow mercaptide was gathered, washed with water, and converted to free di- 
methoxyphenylpenicillenic acid by the procedure used for benzylpenicillenic acid;  Y  =  2.4 
gm (37 per cent) of yellow powder; km~x 335 mtt, ~ =  24,300 (95 per cent ethanol). Purity of 
benzylpenicillenic acid was judged to be 78 per cent based on molar extinction coefficient and 
correcting for 13 per cent unreactive peniciilenic acid disulfide present in the preparation (12). 
Assays of  dimethoxyphenylpenicillenic acid  and  allylmercaptomethylpenicillenic acid  were 
estimated to be 75 per cent and 50 per cent, respectively. Penicillenic acid preparations were 
stored in calcium chloride desiccators at --10  ° and were stable for at least 6 months. 
Preparation of Penicilloyl-Protein Conjugates.--A solution of the penicillenic acid in 95 per 
cent ethanol was added dropwise to the gently stirred 1 per cent solution of the protein in 0.1 
~s phosphate buffer, pH 8, at room temperature. Total ethanol was generally 5 to 10 per cent 
of the reaction volume, pH was maintained at 7.5-8.2 by addition of 1 ~ potassium carbonate 
either manually or from a pH stat. Generally, from 0.3 to 2.5 molar equivalents of the peni- 
cillenic acid per mmole of lysine eNH2 group contained in the protein was used.  Reactions 
were complete within 20 minutes after penicillenic acid was added. Mter an additional 10 
minutes of stirring, the reaction solution was incubated at 37  ° for 1 hour with cysteine (0.1 
M  concentration, pH 7.5)  in order to reduce off penicillenic acid disulfide and other disulfide 
groups. The conjugates were freed of low molecular weight side products by four 24 hour 
dialyses at 4 ° against 2 gin amberlite IRA-400, (400 to 600 mesh) resin (previously equilibrated 
with tris buffer, pH 8.5) suspended in 0.002 ~ tris (tris-(hydroxmethyl)-aminomethane) buffer, 
pH 8.0. Mter a  final dialysis against 0.005 ~  phosphate buffer, pH 8.0, the conjugates were 
stored without preservative at -- 10°C where they were stable for at least 6 months. Additional 
procedural details are given in reference 12. 
Preparation of PcniciUoyl-Polylysine Conjugates.--To  240 mg of PLL.HC1  (1.45  mmoles 
¢-NI-I2) dissolved in 15 ml of 0.25 M potassium bicarbonate, was added dropwise with stirring 
a  solution of 0.66 mmoles of the penicillenic acid dissolved in 1.5 ml of 95 per cent ethanol. 
The stirring was continued for 30 minutes and pH was maintained at 8.0-8.5 by additions of 
1 ~  potassium carbonate. The precipitated penicilloyl-polylysine was centrifuged off, washed, 
suspended in 10 ml of 0.1 ~s carbonate buffer, and reacted at room temperature, pH 10,  with 
3 Performed by Dr, G. M. Hochwald of New York University Medical School. 
D-Allylmercaptomethylpenicillenic acid  appears to  be hydrolized more readily than is 
9-benzylpenicillenic acid. The penicillenic acid rearrangement is much slower for dimethoxy- 
phenylpenicillin than it is for the other 2 penicillins. It requires a lower pH for the rearrange- 
ment to go to completion at room temperature and within a reasonable period of time. 
5 The preparation of dimethoxyphenylpenicillenic  acid was carried out with Dr. R. Schwartz 
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2.0 mmoles succinic anhydride. 6 The filtered reaction solution was adjusted to pH 1.8  with 
1 N HCI. The precipitated penicilloyl-PLL (succinylated) was gathered and washed thoroughly 
with H~O, ethanol, and then ether. Y -  330 mg of white powder. The powder was  dissolved 
in buffered saline (0.15  ~r sodium chloride, 0.02  x¢ phosphate,  pH 8), with additions of 1 M 
NaOH and the solution was stored at -- 10°C, where it was stable for at least 3 months. 
Preparation of Phenylozetyl-Protdn  Conjugates.--To  a  stirred  1 per cent solution of the 
protein in 0.1 ~t pH 8 phosphate buffer at room temperature was added dropwise a solution of 
pheniyacetyl chloride in dioxane  Generally 1 to 3  molar equivalents phenylacetyl chloride 
per mmole ~-NI-I~  contained in the protein was used. Total dioxane was 5 per cent of the re- 
action volume, pig was maintained between 7.5-8.5 with 1 ~  potassium carbonate and the 
reaction was complete within 10 minutes. Precipitated material was centrifuged off and the 
conjugate was purified by repeated dialyses as described above. 
Analyses of the Conjugates.--Protdn  assays were done by duplicate micro-Kjeldahl analyses 
(11a)  and corrected for the nitrogen contribution of penicilloyl groups; mean deviation -4- 3 
per cent. Assay for penicilloyl groups  was done by penamaldate method  as  described  pre- 
viously (7); e at X 285 m/z for BPO, 23,800;  AMMPO, 23,900;  DMPPO, 20,500.  Duplicate 
analyses were done, mean deviation, -4- 3 per cent. Free lysine e-NH2 groups were assayed by 
formol titration (13), pHi, 8.5; pHs, 9.2, with correction for formol blanks; mean deviation for 
duplicate analyses, -4- 5 per cent. 
Univalent Haptens.--Penidlloyl  amines were prepared as their crystalline benzyiammonium 
salts, a-diastereoisomers, and recrystallized several times to constant,  sharp melting points. 
The steric equilibrium mixtures of diastereoisomers of the penicilloyl amines were used in 
hapten inhibition experiments. They were prepared from the a-diastereoisomers by refluxing 
in aqueous solution pH 5, for a period of time sufficient to allow partial racemization to reach 
equilibrium. The resulting solutions contained 98 to 99 per cent of the penicilloyl amines and 
1 to 2 per cent penamaldoyl amines which were formed by rearrangement of penicilloyl amines 
during reflux. Details of these preparations, elemental analyses, physical and chemical proper- 
ties of the penicilloyl amines have been given previously (14). Penieilloyl amine solutions were 
assayed immediately before use in hapten inhibition experiments by the penamaldate method 
as described previously (14).  For analysis of AMMPO-EACA, the hapten was diluted in a 
pH 9,2 carbonate buffer solution containing 1 mg per ml HSA which served to stabilize the 
285 m# peak, ~ -- 23,900  ±  1 per cent. 
lVlonosodium D~-benzylpenicilloate: ~  H20, a-diastereoisomer, was prepared as described 
previously (7),  m.p.,  154-155 °  (micro). Its equilibrinm diastereoisomeric mixture was pre- 
pared by incubation of a 2.0 X  10  -9 ~  sohition of the a-diastereoisomer in B.S., 1 pH 7.5, 37  ° 
for 6 hours; [ct] ~ for a-diastereoisomer, +  130°;  for equilibrium diastereoisomeric mixture, 
+  35.8  ° 
N-Phenylacetylglycine was prepared  by reaction of  1 molar equivalent of phenylacetyl 
chloride with 1.2 equivalents of giycine in aqueous solution at room temperature, pig 11.5. 
Phenylacetylglycine was precipitated from the reaction mixture at pH 1.8 and crystallized 
twice from hot water,  g  --  50 per cent, white plates; mp.,  144-145°;  reported  (15),  142- 
144  °  , 
Antisera.--White rabbits, 4 kg, of either sex were used. Bleedings were from the ear arteries 
(16).  Sera were stored without preservative at -- 10  °. 
Pooled Rabbit Anti-Benzylpenicilloyl Serum, Globulin Frar,  tion.--Six  rabbits were immunized 
with a preincubated mixture of potassium benzylpeniclllin and pooled normal rabbit serum 
emulsified in complete Freund's adjuvant.  The immunization and  bleeding schedules have 
8 Under these conditions, succinic anhydride reacts readily with the e-NH2 groups of poly- 
lysine, but does not react appreciably with the thiazolidine secondary amine of the BPO mole- 
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been described previously (7). The serum from the 6 animals were pooled, and the globulin 
fraction from 260 ml serum was separated by precipitation at room temperature with am- 
monium sulfate, at a  final concentration of 1.75 ~, pH 7.2.  The precipitated globulin was 
washed thoroughly with 1.75 M ammonium sulfate. It was suspended in water, the suspension 
dialysed extensively against B.S.  1 pH 7.3, and finally dissolved in a volume of 200 nil. The 
product was free of albumin by paper electrophoretic and immunoelectrophoretic analyses.  8 
Rabbit anti-(BPO~-RSA), Sera 4 and 5.--Two rabbits were immunized by the following 
schedule: Day  1:5 mg antigen dissolved in  1 ml B.S. and  emulsified with  1 ml complete 
Freund's adjuvant was distributed into 4 dorsal subcutaneous sites. Day 30: The same dosage 
was distributed into 8 dorsal intradermal sites. Days 61, 62, 63:2 mg antigen was injected 
intravenously. Days 70, 71: Animals were bled and the serums from the two bleedings were 
combined for each animal. 
Rabbis anti-(BPO4-RSA),  Serum 34.---One rabbit was immunized by the following schedule: 
Day 1:5 mg antigen dissolved in 1 ml B.S. and emulsified with 1 ml complete Freund's ad- 
juvant was distributed into 8 dorsal intradermal sites. Days 30, 31:2 mg antigen was injected 
intraperitoneally twice daily. Days 37, 38, 39: Animal was bled and the sera from the bleed- 
ings were combined. 
Dexompleraentation of Sera.--A washed ovalbumin-rabbit antiovalbumin precipitate pre- 
pared at equivalence was finely suspended in the serum. The suspension was incubated at 
37  ° for I  hour, and at 4 ° for 2 days with intermittent resuspension, and the precipitate was 
removed by centrifugation. 100/~g precipitate N per ml serum was used as recommended by 
Maurer and Talmadge (17). Quantitative precipitin analyses (11 b) of the antisera before and 
after decomplementation showed a  decrease of 60 to 90 #g protein per ml precipitated at 
equivalence, consistent with reported experience (17).  A second decomplementation did not 
reduce further the weight of antibodies precipitated at equivalence. 
Quantilative Precipitin  Analyses  of Antisera.--The  methods  developed by Heidelberger 
were used (11 b). Antisera were clarified by repeated centrifugation at 12,000 RPM. To 0.50 
ml aliquots of clarified antiserum or globulin fraction was added increasing amounts of antigen 
dissolved in 0.50 B.S.,  I pH 73. Reaction mixtures as well as antigen (at various quantities) 
and antiserum controls were set up in duplicate and incubated at 37 ° for 1 hour, and at 4 ° 
for  68  hours  with intermittent  resuspension  of  the precipitates.  Preliminary  experiments 
showed that maximum precipitation was achieved under these conditions in all systems studied 
here. Precipitates were washed 3 times with 2.0 ml of ice cold saline, alr-dried, dissolved in 
0.1  N sodium hydroxide, and measured aliquots were analyzed by the Folin method  (18); 
mean deviation in O.D. at Xmlffi, 750 m/~ -4- 3 per cent. The Folin method was standardized 
against Kjeldahl-analyzed solutions of RGG  1 (Fx H, Pentex Inc., Kankakee, Illinois), several 
penicilloyl-HGG preparations, several penicilloyl-RSA, penicilloyl-HSA, and penicilloyl-PLL 
preparations. Color values per/~g conjugate protein for RGG and the HGG conjugates were 
identical (difference  less than 3 per cent). Color values per/~g protein for the serum albumin 
conjugates were 40 to 48% of that for T-globulin; those for PLL conjugates were 50 per cent 
of the color value for X-globulin.  In the zone of antibody excess, the weight of antibodies pre- 
cipitated from serum was obtained by subtracting the weight of antigen added  (multiph'ed 
color value antigen 
by the ratio,  from the total protein precipitated.  Supematants were 
color value globulin) 
negative for antigen in the antibody excess zone, and gave weak positive reactions at the zone 
of maximal antibody precipitation  (equivalence). It was arbitrarily assumed  that approxi- 
mately 10 per cent of the added antigen was not precipitated at equivalence, and this addi- 
tional correction was used in calculating the weights of antibodies precipitated at equivalence. 
If the amount of antigen remaining soluble at equivalence is actually 0 to 20 per cent, the 
maximum error introduced into the weights of antibodies precipitated at equivalence would 
be 1 per cent for antibodies precipitated by PLL conjugates, and 4 per cent for antibodies Bxgs~vm B.T.v.Vn~  167 
precipitated by HGG conjugates. The maximum over-all experimental error in these analyses 
was judged to be ±5 to 7 per cent. 
Quantitative Hapten Inhibition of Predpitation.--Methods  developed by Landsteiner  (19) 
and by Panling eta/. (20) were used. For experiments in Fig. 5, haptens at increasing concen- 
trations dissolved in 1.00 ml B.S., pH 7.3 were mixed with 0.50 ml aliquots of the clarified 
rabbit anti-BPO globulin fraction, followed immediately by the addition of sufficient antigen 
dissolved in 0.50 ml B.S. to reach equivalence. For the experiments in Figs. 3 and 4, haptens 
dissolved in 0.50 ml B.S. were mixed with 1.00 ml globulin fraction foUowed by the addition 
of 500 #g antigen in 0.20 ml B.S. These mixtures as well as uninhibited antigen-globulin frac- 
tion mixtures and antigen and globulin fraction controls diluted in B.S. were set up in dupli- 
cate. Tubes were incubated, and precipitates were washed and analyzed by the Folin method 
as described above; mean deviation, ±3 per cent. Maximum precipitation was achieved under 
these conditions. The weights of protein precipitated from the uninhibited antigen-globulin 
fraction mixtures were: 240/~g for experiments in Fig. 5; and 80 ~g for experiments in Figs. 
3 and 4. Antigen and globulin fraction controls precipitated a total of 5 to 10 #g protein. Un- 
decomplemented globulin fraction was used in these experiments as the curves obtained from 
inhibition of precipitation of the globulin fraction by BPO~-HGG with BPO-EACA  1 were 
identical for decomplemented and undecomplemented globulin fraction. Repeat hapten in- 
hibition curves were done for several haptens at different times and using different hapten 
preparations.  Mean deviation in hapten concentration required for 50 per cent inhibition of 
precipitation was ±5 per cent. 
]RESULTS 
Analysis of Conjugates.--Table I shows the comparisons between the numbers 
of penicilloy1 groups  introduced into  various  conjugates  by  reaction with 
penicillenic  acids,  and the numbers of lysine ¢-NH2 groups  blocked.  The two 
figures are in good agreement, demonstrating that penicilloyl groups are bound 
covalently  to  carrier  proteins  predominantly  as  penicilloy1-1ysine groups. 
Ultraviolet absorption spectra of the penicilloy1-protein and penicilloyl-PLL  1 
conjugates exhibited absorption peaks at 285 In# as described and discussed 
previously (7).  The penicilloyl  conjugates were free of detectible peniciUenic 
disulfide groups by ultraviolet spectrophotometric analysis (7), except for the 
DMPPO-protein conjugates. Mter several treatments of the DMPPO-protein 
conjugates with cysteine and with mercaptoethylamine, they still exhibited an 
absorption shoulder at 340 m# with optical densities corresponding to less than 
one penicillenic disulfide group per mole conjugate. The phenylacetyl-protein 
conjugates (prepared by reaction of phenylacetyl chloride with proteins) con- 
rained 14-26 fewer ¢-NH~ groups per mole than did the native proteins (Table 
I). Thus the conjugates contained at least that number of phenylacetylamine 
groups bound covalently to lysine side chains. 
Absence of Antibodies Complementary to  the Phenylacetylamine End of the 
BPO Molecule.T--In the following experiments the globulin fraction of a pooled 
7 The phenylacetylamine  group could act as an antigenic determinant.  Five guinea pigs 
sensitized with PAC~-guinea pig albumin exhibited strong Arthus and delayed skin reactivity 
to  the immunizing conjugate and  negative reactions to native and  acetylated  guinea  pig 
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rabbit  anti-BPO  serum  (prepared  by  immunization  with  benzylpeniciUin)  s 
was analyzed for the presence of anti-phenylacetylamine antibodies,  and anti- 
thiazolidine carboxylic acid antibodies.  Fig. 2 shows that no anti-phenylacetyl- 
amine  antibodies  could be  detected  in  the  globulin  fraction  by quantitative 
precipitation  with  PAC2~-HGG,  PAC26-RGG and  PACt4-RSA;  whereas  the 
TABLE I 
Analysis of Penicillofl and Phenylacetyl Conjugates of Various Proteins 
Conjugate* 
BPO-HGG 
DMPPO-HGG 
AMMPO-HGG 
BP0-RSA 
BPO-HSA 
DMPPO-RSA 
DMPPO-HSA 
BPO-PLL 
DMPPO-PLL 
PAC-HGG 
PAC-RGG 
PAC-RSA 
Preparation 
A 
A 
A 
A 
B 
C 
A 
B 
A 
B 
C 
D 
A 
C 
A 
A 
A 
A 
A 
Penicilloylgroupsper 
mole conjugate 
(average)$ 
22 
22 
42 
27 
18 
4.4 
5.0 
13 
27 
13 
22 
18 
19 
15 
5.6 
5.6 
0 
0 
0 
Lyslne~-NHz groups 
blocked per mnle 
conjugate (average) 
2O 
25 
-[I 
3.6 
5.2 
10 
27 
13 
23 
18 
15 
15 
22 
26 
14 
* See footnote 1 for abbreviations. 
Penicilloyl analysis by penamaldate  method;  protein  by micro-Kjeldahl  corrected for 
nitrogen contribution of penicilloyl groups. Molecular weights: HOG, 160,000; RSA, 69,000; 
HSA, 69,000; PLL 20 units average, 2,600; RGG, 160,000 (See Experimental). 
§ Lysine  ,-NH, by formal titration,  protein  analyzed as above.  *-NH2 groups per mole 
found for native proteins were: HGG, 89; RSA, 58; HSA, 56; RGG, 88. 
I[ (--) analyses not done. 
globulin  fraction  contained  265  #g per  ml  antibody  precipitable  by  BPO22- 
HGG.  No  anti,phenylacetylamine  antibodies  could  be  detected  by  PCA  in 
guinea pigs (21) using the globulin fraction in 1 to 20 dilution and 1 mg of the 
PAC-protein conjugates as  antigens,  whereas  with  250 #g of BPO22-HGG as 
s Immunization of rabbits with benzylpeulcillin results in the formation of anti-BPO anti- 
bodies. It is believed that benzylpenicillin rearranges to benzylpenicillenie acid in dvo which 
reacts with tissue proteins to form antigenic BPO-protein conjugates (7). BERNARD B.  LEVINE  169 
antigen,  the globulin fraction  gave positive PCA  reactions  to a  dilution  of 
1 to 2500. 
Absence  of Antibodies  Complementary  to  the  Thiazolidine--Carboxylic Acid 
End of the BPO Molecule.--Anti-BPO antibodies which encompass only the 
thiazolidine  ca~boxylic acid portion of the BPO molecule should be precipitated 
equally well by conjugates containing AMMPO or DMPPO groups provided 
600 
A 
f- 
PROTEIN 
PREC  I P ITATED 
PER ML 
00  __~  ~__  .~  ,  m  ~  ,  , 
150  5Q0  1000  2000  30(]0 
/J~  ANTIGEN  ADDED 
FIO. 2. Precipitation of rabbit anti-benzylpenidUoyl  pooled serum (globulin fraction)  by: 
•  BPOm-HGG; ~, BPO~-HGG (decomplemented globulin fraction); O, DMPPO~-HGG; 
~,  AMMPO~-HGG; •  PAClt-RSA,  PAC~e-RGG, PAC~-HGG.  (~)  indicates  point  of 
maximal antibody precipitation. 
that there is no steric interference from the N-7 side chain.  Fig.  1 shows that 
these penicilloyl  groups  are identical  to  the BPO group  with regard  to  the 
structure  of  the  thiazolidine  carboxylic  acid  portion  of  the  molecule,  and 
differ only in the structure of the side chain on the N-7 nitrogen atom. Also, 
Fisher-Hirschfelder-Taylor scale models of these molecules  (Fig.  1) show that 
the  thiazolidine  carboxylic acid  ends  of  these penicilloyl molecules may be 
presented to a hypothetical anti-thiazolidine  binding site without steric inter- 
ference from the N-7 side chain. 
Figure 2 shows the results of quantitative precipitation analysis of the anti- 
BPO globulin fraction using BPO2~-HGG,  DMPPO2~-HGG and AMMPO42- 
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FIG. 3. Hapten inhibition of theprecipitation of pooled  rabbit anti-BPO globulin fraction by 
l 
AMMPO~-HGG, shown by solid lines. O  indicates the corrected BPO-EACA concentration 
required for S0 per cent inhibition (see footnote 11). For comparison is shown hapten inhibi- 
tion of precipitation of the anti-BPO globulin fraction by BPOm-HGG  (broken lines;  data 
from Fig. 5). Also shown is hapten inhibition of the precipitation of anti-BPO globulin fraction 
(which had been absorbed with DMPPO~-HGG)  by AMMPO42-HGG. Haptens  are: +, 
BPO-EACA; O, AMMPO-EACA. 
HGG  as antigens.  The  DMPPO,,-HGG  and  AMMPO,,-HGG  antigens  pre- 
cipitated a maximum of 9 per cent  9 of the weight of antibodies precipitated by 
9 The maximum amount of antibody protein precipitable from  the globulin fraction by 
DMPPO,~-HGG and AMMPO42-HGG was 25/~g. per ml., part of which is probably comple- 
ment protein. In comparison BPO~-HGG precipitated 345 ~g. per ml. protein from the un- 
decomplemented  globulin  fraction and 265  ~g. protein per ml. from the  decomplemented 
globulin fraction. The difference which is presumably complement protein would be 80 ~g. per 
ml. providing the Folin color value for complement protein is equal to that for "),-globulin. BF.I~ARD B.  LEVINE  171 
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Fro. 4. Hapten inhibition of theprecipitation of pooled rabbit anti-BPO globuEu fraction by 
DMPPO~-HGG with BPO-n-propylamine (~);  and  with  DMPPO~-propylamine  (O). 
/ 
~)  indicates the  corrected BPO~-propylamine concentration required for 50 per cent 
inhibition (see footnote 11) For comparison is shown hapten inhibition of precipitation of the 
anti-BPO  globulin  fraction  by  BPO~-HGG  with  BPO-n-propylamine  (O),  and  with 
DMPPO-n-propylam/ne (D) (data from Fig. 5). 
BPO~2-HGG. PCA analysis in guinea pigs (21) showed the globulin fraction to 
give positive reactions to a dilution of 1 to 2500 with BPO~-HGG as antigen 
and to a dilution of 1 to 100 with DMPPOs2-HGG as antigen. The maximum 
amount of antibodies in the globulin  fraction which could be specific for only 
the thiazolidine carboxylic acid portion of the BPO molecule is 9 per cent of 
the antibodies detectible by BPO~s-HGG.  The other 91 per cent required for 
detection a  conjugate containing  the entire BPO structure.  If the and-BPO 
antibodies precipitable by DMPPO~2-HGG and AMMPO4~-HGG are indeed 
complementary to only the thiazolidine carboxylic acid end of the peniciUoyl 172  DIMENSIONS  OF ANTIBODY-COMBINING  SITES 
molecule, the precipitation of these antibodies should be inhibited equally well 
by univalent haptens which contain the BPO, AMMPO or DMPPO groups. 
Fig. 3 shows the results of quantitative hapten inhibition experiments which 
compare  the  abilities  of  BPO-EACA  and  AMMPO-EACA  to  specifically 
inhibit the precipitation of the anti-BPO globulin fraction by AMMPO,~-HGG, 
and  Fig.  4  shows  the  comparative  abilities  of  BPO-n-propylamine  and 
TABLE  II 
Decrease in Standard Free Energy of Binding,  (--AF°), of Penlcilloyl Haptens 
to the Anti-BPO Globulin Fraction 
Hapten 
BPO-EACA 
BPO-s-octylamine 
BPO-~-amylamine 
BPO-~-propylamine 
BPO-benzylamine 
BPO-amine 
Benzylpenicilloate 
AMMPO-EACA 
DMPPO-n-propyla- 
miue 
Phenylacetylglycine 
S 
\ 
R .CO.N,II.CH--& CICH,]= 
R'--iO  ~H-~H.cooe 
R' 
CoH,CHr- 
JJ 
J~ 
J~ 
CH2-~-CH--CHr-S--CH2  -- 
OCH, 
\ 
OCHs 
C6HICI-I~CONHCH~COO  e 
R" 
OOOC--(CH=)  5--NH-- 
CH,(CH,)r--NH-- 
CH,(CH~)4--NH-- 
CH,(CH,)r-NH-- 
C~H,--CHr--NH-- 
NH~-- 
eO-- 
~OOc--(CH~)  ~--NH-- 
CHs(CH2h--NH-- 
a(--~) 
(BPO-EACA - 
Other Hapten) 
cal t~r mole 
0 
170 
170 
170 
460 
1450 
1900 
3300 
3500 
Cio BPO-EACA 
A (AF  °) =  --2.303 RT logl0 C~ other hapten  (Kabat, reference 1). 
* Equilibrium diastereoisomeric mixture of penicilloyl haptens. 
~/Assumed  AF  ° for BPO-EACA, --7500 cal/mole (23-25). 
DMPPO-n-propylamine to specifically inhibit the precipitation of the globulin 
fraction by DMPPO22-HGG 1°. Chemical structures of the haptens are shown 
10 The penicilloyl haptens were used as their sterically equilibrated diasteriosomeric mix- 
tures (14)  since rabbit anti-BPO antibodies prepared by immunization with benzylpenicillin 
are specific for the diasteriosomeric BPO groups rather than for the ot-diastereoisomer (7). 
The molar specific rotations of the sterically equilibrated diastereoisomeric mixtures of the 
BPO-amines and of AMMPO-EACA were essentially identical (14). Thus it is probable that 
the ratio of diasterioisomers present at equilibrium is the same for these peuicilloyl amines. 
Also it appears likely that  the ratio is the same for BPO-lysine groups in BPO conjugates 
prepared by reaction of proteins with D-benzylpenicillenic acid. These ratios appear to differ 
from the ratios of diastereoisomers present in  the sterically equilibrated  diastereoisomeric 
mixtures of D-a-benzylpenicilloate (see Experimental) and DMPPO-n-propylamine (14). BERNARD B.  LEVINE  173 
in Table II. In both systems, the BPO hapten was the more effective inhibitor. 
Precipitation of globulin fraction by AMMPO4,-HGG was inhibited 4.9 times 
as effectively by BPO-EACA as by AMMPO-EACA;  hapten  concentrations 
required  for  50  per  cent  inhibition were  4.1  x  10  -s moles/liter BPO-EACA 
and 2.0  X  10  -b moles/liter AMMPO-EACA.  n-13  Precipitation of the globulin 
fraction by DMPPO2,-HGG was inhibited 11.7 times as effectively by BPO-n- 
propylamine than by DMPPO-n-propylamine; hapten concentrations required 
for  50  per cent inhibition were  1.4  X  10  -s  moles/liter  BPO-n-propylamine 
and 1.6  X  10  -5 moles/liter DMPPO-n-propylamine. n-Is 
Although  the  anti-BPO  antibodies  precipitated  by  AMMPO42-HGG  and 
DMPPO22-HGG  could distinguish  the  BPO  hapten  from  the AMMPO  and 
DMPPO  haptens,  these  "cross-reacting"  anti-BPO  antibodies  distinguished 
less well between BPO and AMMPO  or DMPPO  haptens  than  did the anti- 
BPO  antibodies requiring BPO22-HGG for precipitation. For  example, Fig. 3 
shows that the precipitation of the  anti-BPO globulin fraction  by AMMPO4,- 
HGG required for 50 per cent inhibition 4.9 times as high a molar concentration 
of AMMPO-EACA,  as of BPO-EACA,  whereas  precipitation of  the globulin 
fraction by BPOss-HGG required for 50 per cent inhibition 30 times as high as 
molar concentration of AMMPO-EACA as of BPO-EACA?  3 Further, when the 
globulin fraction was first absorbed with DMPPO22-HGG, precipitation of the 
11 The total hapten concentrations required for 50 per cent inhibition of precipitation of 
the globulin fraction by A-~MPO4~-HGG were corrected for specific binding of these haptens 
by the anti-BPO antibodies which are not precipitated by AMMPO42-HGG. This correction 
was calculated from the mass action Law assuming average association constants for antibody 
hapten binding of 106 for BPO-EACA and 104 or 105 for AMMPO-EACA. The total antibody- 
combining  site concentration in the inhibition mixtures was  1.7  X  10-  s moles/liter. For 
BPO-EACA, the observed total hapten concentration required for 50 per cent inhibition was 
5.4  X  10  -'s moles/liter, and  the  correction for  nou-precipitable antibody-bound hapten 
amounted to 1.3 X  10-  s moles/liter. For AMMPO-EACA, the observed total hapten concen- 
tration required for 50 per cent inhibition was 2.0 X  10-  5 moles/liter, and the correction for 
non-precipitable antibody-bound hapten was less than 1 X  l0  -6 moles/liter, and is thus neg- 
ligibly small. Similar corrections  were made for total hapten concentrations required for 50 
per cent inhibition of precipitation of the globulin fraction by DMPPO~-HGG. For BPO- 
n-propylamine the observed total hapten concentration required for 50 per cent  inhibition 
was 2.3 X  10  -6 moles/liter and the correction amounted to 0.9 X  10-  s moles/liter. The cor- 
rection for DMPPO-n-propylamine was negligibly small. 
12 Inhibition was specific as, in the concentrations used, these haptens did not inhibit pre- 
cipitation of rabbit anti-ovalbumin and rabbit anti-bovine "y-giobulin antibodies by their 
respective antigens. 
13 Inhibition was carried out on the AMMPO-HGG- and the DMPPO-HGG-precipitating 
systems in far antigen excess. This was done to increase the amount of protein precipitated 
(there is no inhibition of precipitation in far antigen excess, Fig. 2) and to increase also the 
concentration of haptens required for 50 per cent inhibition. For the BPO-HGG precipitating 
system, inhibition was carried out at equivalence. The ratio of the concentrations of haptens 
(i.e. AMMPO-EACA rersus  BPO-EACA)  required for 50 per cent inhibition is the same at 
equivalence as it is in far antigen excess (20). 174  DrM-~.NSIONS OF ANTIBODY-COMBINING SITES 
rema~nlng  anti-BPO  antibodies  by  BPO2~-HGG  required  for  50  per  cent 
inhibition  38 times as high  a  molar  concentration  of AMMPO-EACA as of 
BPO-EACA (Fig. 3). Similarly,  Fig. 4 shows that precipitation of the anti-BPO 
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FIG. 5. Hapten inhibition of precipitation of the pooled rabbit anti-BPO globulin fraction 
by BPO~-HGG. Penicilloyl  haptens are equilibrium diastereoisomeric mixtures (see Table II 
for  structural  formulas).  O,  BPO-EACA;  D,  BPO-n-octylamine; x,  BPO-n-amylamine; 
O,  BPO-n-propylamine;  0,  BPO-benzylamine;  /x,  BPO-amine;  •  benzylpenicilioate; 
*, AMMPO-EACA;., DMPPO-n-propylamine; ~  phenylacetylglycine. 
globulin fraction by DMPPO22-HGG required for 50 per cent inhibition  12 
times  as  high  a  concentration  of  DMPPO-n-propylamine  as  of  BPO-n- 
propylamine  whereas precipitation  of  the globulin fraction  by BPO2~-HGG 
required 260 times as high a  concentration of DMPPO-n-propylamine  as  of 
BPO-n-propylamine.  ~ ~ERNA~DB.  L~Vn~  175 
Quantitative Hapten Inkibition  of Precipitation of tke Anti-BPO  Globulin 
Fraction by BPO22-HGG. In previous experiments with pooled rabbit anti-BPO 
whole sera (prepared by immunization of rabbits with benzylpenicillin),  hxpten 
inhibition  experiments indicated  that  the  anti-BPO  combining  sites  were 
complementary also for the lysine side of carrier proteins (7). In the present 
experiments, an albnmln-free globulin  fraction of a  pooled  rabbit anti-BPO 
serum was studied to avoid reversible  binding of haptens by serum albumin 
(22). A group of BPO amine  1° univalent hxpteus which differ in the lengths of 
the amide side chains (see Table II for chemical structures) as welt as free 
benzylpenicilloic acid, AMMPO-EACA, DMPPO-n-propylamine, and phenyl- 
acetylglycine, were  compared with  regard  to  their  abilities  to  specifically 
inhibit precipitation of the rabbit anti-BPO pooled serum globulin fraction by 
BPO22-HGG.  ~ Results are plotted, per cent inhibition versus log total hxpten 
concentration as suggested by Pauiing et al. (20) in order to facilitate expression 
of the data in energetic terms. The results in Fig. 5 show a family of parallel 
sigmoid inhibition curves indicating that the anti-BPO-globulin fraction shows 
the same degree of heterogeneity in antibody-hapten binding energies toward 
each of these hxptens (20). Under these conditions,  the difference in the log 
molar concentrations of two hxptens required to achieve 50 per cent inhibition 
is proportional to  the difference  in average standard free energy of hapten 
binding to antibody (--AF  °) between these two hapteus (20). Table II lists 
A(--AF  °)  between BPO-EACA and the other haptens  calculated from  the 
formula given by Kabat (1).  The most effective inhibitor was BPO-EACA; 
the  effectiveness  of  the  other  BPO-amines  was  intermediate between  the 
effectiveness of BPO-EACA and BPO-amine. The sharp drop in --AF  ° between 
BPO-amine  and  benzylpenicilloate may be  due  to  repulsive effects  of the 
caxboxylate ion and the change in electronic distribution induced in the BPO 
molecule by this ion. This decreased binding ~finity may be due also to the 
difference between the ratio of diastereoisomers  in the sterically equilibrated 
benzylpenicilloate solution, and this ratio in solutions of sterically equilibrated 
BPO-amines. 1° Similarly, this steric factor may be responsible  in part for the 
relatively poor  binding  of  DMPPO-n-propylamlne.  The  equal  inhibitory 
effectiveness of the water-soluble BPO-EACA and the poorly soluble  BPO-n- 
octylamine indicates  that  these inhibition  results  reflect specific antibody- 
binding differences rather than reflecting non-immunological  properties of these 
haptens (e.g., solubility). 
Precipitation of Rabbit Anti-(BPO-RSA)  Sera witk Penicilloyl Conjugates 
of RSA and Heterologous Carriers.--Sera from individual rabbits were used and 
decomplemented to avoid coprecipitation of complement protein (17). Neither 
native or acetylated RSA precipitated antibodies from these sera, and for sera 
6 and 34, precipitation at equivalence by penicilloyl conjugates was inhibited 
completely  by 1.0  X  10  --~ ~s BPO-EACA. For mixtures of serum 5 with BPO- 176  DIMENSIONS OF ANTIBODY-COMBINING  SITES 
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FIG. 6. Precipitation  of decomplemented rabbit anti-(BPO~-RSA)  sera  5 and 6 with  : 
0, BPO~-RSA; V, BPOzz-HGG; &, BPOa.6-PLL; ,,  DMPPO~-RSA; Zk, DMPPOs.6-PLL; 
V, DMPPO~-HGG; I-1, DMPPO15-HSA. The numbers refer to the maximum  weights (/~g 
per ml) of antibodies precipitated.  The figures with asterisks have been corrected for "non- 
BPO antibody." (see text). 
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Fla.  7. Precipitation  of decomplemented  rabbit anti  (BPO4.4-RSA) serum 34 with:  O, 
BPOzz-RSA: A, BPOIa-HSA; ©, DMPPOla-RSA; V, DMPPO13-RSA; A, DMPPO~-RSA; 
,,  DMPPO15-HSA, 
EACA, amounts of BPO2~-HGG and BPO27-RSA sufficient to reach equivalence 
precipitated  less than 30 #g antibody protein per ml, or 3 to 4 per cent of the 
weight of antibodies precipitated  by these antigens at equivalence.  This small 
correction for "non-BPO"  antibody was made.  Thus,  antibodies  precipitated ~ERNAS.V B.  L~vr~  177 
from the three sera were judged to be specific for the BPO group. The results 
of quantitative precipitation analyses are shown in Figs. 6, 7. Penicilloyl conju- 
gates of the immunizing  protein carrier  (RSA) precipitated more antibodies 
from serums 5 and 6 than did penicilloyl  conjugates of heterologous carriers 
(HGG, HSA, and  PLL). This  "carrier  effect" was more pronounced for the 
anti-BPO antibodies which were precipitated by DMPPO conjugates (termed 
cross-reacting antibodies)  than it was for the "non-cross-reacting" antibodies 
which required BPO conjugates for precipitation.  For example, for serum 5, 
DMPPO~-RSA precipitated 1.9 times the weight of antibodies precipitated by 
DMPPO22-HGG, whereas BPO27-RSA precipitated only 1.1 times the weight 
of  non-cross-reacting  anti-BPO  antibodies  14  precipitated  by  BPO22-HGG 
(Fig. 6). For serum 6, DMPPO~-RSA precipitated 3.0 times the weight of anti- 
BPO  antibodies  precipitated  by DMPPO22-HGG, whereas BPO27-RSA pre- 
cipitated only 1.4 times the weight of non-cross-reacting  antibodies precipitated 
by BPO22-HGG. The "carrier  effect" was least for the PLL conjugates, and 
most marked for the HSA conjugates (Figs. 6, 7). Fig. 7 shows also a comparison 
of  the  abilities  of  three  different DMPPO-RSA preparations  to precipitate 
anti-BPO  antibodies from serum 34  (rabbit anti-BPO4-RSA).  Two different 
DMPPO-RSA conjugates  which  were prepared  in  the  same  way  (1  molar 
equivalent dimethoxyphenylpenicillenic acid per mole lysine ~-NH~, pH 7.5- 
8.0,  6  per  cent  ethanol)  precipitated  equal  weights  of  antibodies  from  the 
serum, i.e. DMPPO18-RSA  (prep. D), 265 #g per ml 4- 5 per cent; DMPPO13- 
RSA (prep.  B) 250 #g per ml 4- 5 per cent. A third preparation,  DMPPO22- 
RSA (prep.  C), prepared under more severe conditions, (2.5 molar equivalents 
of the penicillenic  acid per mole lysine e-NH2, pH 8.0-9.0, 15 per cent ethanol) 
precipitated only 130 #g per ml 4-  5 per cent of antibodies from the serum. 
All 3 conjugates were prepared from the same penicillenic acid and RSA prepa- 
rations, but at different times. 
DISCUSSION 
The foregoing  experimental results demonstrate that at least a large portion 
of rabbit antibodies prepared against the benzylpenicilloyl (BP0) bifunctional 
haptenic group are specifically  adapted to a large antigenic unit consisting of 
the entire BPO group,  the lysine side chain  through which BPO groups are 
bound predominantly  to  proteins, and  structural  areas  of  the  immunizing 
carrier protein (probably adjoining the point of attachment of the BPO group). 
No antibodies which are specifically adapted to only the phenylacetylamine or 
14 The weight of non-cross-reactlng anti-BPO antibodies was obtained by subtracting the 
weight of antibodies precipitated by a DMMPO conjugate from the weight of antibodies 
precipitated by its homologous  BPO conjugate. After absorption of a serum with BPOsv-RSA 
or with BPO~-HGG, no additional antibodies could be precipitated by DMPPO27-RSA  or 
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the thiazolidine  carboxylic acid portions  of the bifunctional BPO  molecule 
could be detected. 
Of interest is the observation that phenylacetylglycine  could bind specifically 
to a pooled rabbit anti-BPO serum glob,lin fraction (Fig. 5) whereas several 
phenylacetylamine-protein  conjugates could not detectibly react with the anti- 
BPO globulin  fraction by specific precipitation (Fig.  2) or by PCA reaction. 
These findings are consistent with the view that the antibody-combining site 
is  an intramolecular cavity (23) rather than a  specific patch on the surface 
of the antibody molecule.  Thus,  whereas the low molecular weight phenyl- 
acetylglycine molecule can pass  unrestricted into  the  large combining  site 
cavity to reach its specific combining surface, such a passage may be impossible 
for  phenylacetylamine residues  bound  closely to  a  high  molecular weight 
protein. 
Rabbit  anti-BPO antiserums could be fractionated into two distinct frac- 
tions of anti-BPO antibodies on the basis of their abilities  to cross-react with 
dimethoxyphenylpenicilloyl  (DMPPO)  and  allylmercaptomethylpenicilloyl 
(AMMPO) conjugates. For the pooled rabbit anti-BPO serum globulin fraction, 
a maximum of 9 per cent of the weight of antibodies precipitated by BPO2~- 
HGG could be precipitated by DMPPO22-HGG  or by AMMPO4~-HGG (Fig. 
2). Based on quantitative hapten inhibition data, anti-BPO antibodies in the 
cross-reacting fraction (9 per cent) as well as in the non-cross-reacting fraction, 
(91 per cent) appear to be specifically adapted to the entire BPO molecule 
rather than to the thiazolidine  carboxylic acid portion of the BPO molecule 
alone. Specific precipitation of both fractions was inhibited more effectively  by 
BPO haptens than by homologous AMMPO or DMPPO univalent haptens 
(Figs.  3,  4).  However,  the  non-cross-reacting anti-BPO  antibodies  (which 
require BPO-conjugates for precipitation) could distinguish between the BPO 
and AMMPO or DMPPO haptens better than could the cross-reacting  anti- 
BPO  antibodies.  For  example,  a  38-fold  greater  molar  concentration  of 
AMMPO-EACA than BPO-EACA was required for 50 per cent inhibition of 
precipitation of the non-cross-reacting anti-BPO antibodies, whereas only a 
4.9-fold greater molar concentration of AMMPO-EACA than BPO-EACA was 
required for 50 per cent inhibition of precipitation of the cross-reacting anti- 
BPO antibodies.  Thus, the cross-reacting anti-BPO antibodies appear to be 
less closely fitted to the haptenic groups (i.e.,  less avidly bound) than are the 
non-cross-reacting anti-BPO antibodies. The possibility  cannot be excluded, 
however, that the cross-reacting fraction of anti-BPO antibodies contains some 
antibody molecules  with specificity only for the thiazolidine  carboxylic acid 
portion of the BPO group. Regardless of this possibility,  it is clear that at least 
the bulk of anti-BPO antibodies are specifically adapted to the entire  BPO 
haptenic group. 
Anti-BPO antibodies are specifically adapted also  to  the  6  carbon  lysine BERNARD  B.  LEVINE  179 
Side chain  through  which  penicilloyl  groups  are  bound  predominantly  to 
proteins.  Thus,  BPO-EACA (with a  6 carbon amide side chain)  was a  more 
effective specific inhibitor  of precipitation  of anti-BPO antibodies than  were 
BPO-amines with smaller amide side chains  (Fig.  5). The contribution made 
by the 6 carbon chain to specific antibody hapten binding was 460 cal per mole, 
[A(--AF  °) between BPO-EACA and BPO-amine, see Table II.] Assuming an 
average --AF  ° for antibody binding of BPO-EACA to be 7500 cal per mole,  16 
the binding contribution for the 6 carbon side chain is small, roughly 6 per cent. 
In comparison for the dinitrophenyl (DNP) system, the contribution made to 
specific binding by the lysine side chain is considerably larger.  Using  hapten 
dissolution of precipitates, Farah et al.  (26) found e-DNP-lysine to be 30 times 
as effective as was DNP-glycine, corresponding  to a A(-z~F  °) of 1900 cal per 
mole.  Also,  Velick  et  al.  (27)  using fluorescent quenching  techniques  found, 
for a purified rabbit anti-DNP antibody preparation, association constants of 
4.2  X  l0  s and 1.4  X  10  e for the binding of e-DNP-lysine and DNP-acetate 
respectively. These figures  correspond  to a  ~(--AF  °)  of 3200  cal per mole, 
where  --AF  ° for the binding  of e-DNP-lysine was 11,300 cal.  per mole.  Al- 
though more data along these lines are needed, the difference in the contribution 
made by the lysine side chain to antibody hapten binding for the DNP and 
BPO systems may be ascribed provisionally to the difference  in size of these 
haptens. 
Anti-BPO antibody-combining sites show specificity also for structures  of 
the immunizing  carrier protein. Thus for three antisera from individual rabbits 
immunized with BPO-RSA, peniciUoyl conjugates of the immunizing  carrier 
(RSA) precipitated more antibodies than did conjugates of three heterologous 
carriers  (PLL, HGG, and HSA) (Figs. 6, 7). The different precipitation abilities 
found for conjugates of three different heterologous carriers  (Figs. 6, 7) suggest 
that these abilities may be defined also by factors other than specific structural 
adaptation  between  the  combining  site  and  the  carrier.  Thus  non-specific 
protein-protein  interactions  between  the  antibody  and  antigen  molecules, 
as well as repulsive forces between the antibody-combining site and the more 
or  less  poorly fitted  heterologous  carrier  surface,  would contribute  also  to 
the  total binding  between antigen  and  antibody.  Further,  solubility factors 
may also determine, in part, the ability of a conjugate to precipitate antibodies. 
The contribution made by the carrier to precipitation of anti-BPO antibodies 
was  considerably  greater  for  antibodies  precipitated  by the  DMPPO  con- 
jugates (relatively poorly fitted to hapten)  than it was for the anti-BPO anti- 
bodies which require BPO conjugates for precipitation (relatively closely fitted 
to hapten)  (Figs.  6, 7). These results suggest that as the binding energy con- 
tributed  by antibody-hapten  interaction  increases,  the binding  contribution 
made  by the  carrier  becomes less  important  for precipitation.  Accordingly, 
x~ Values of this order have been found for other hapten-antibody interactions (23-25). 180  DIMENSIONS  OF ANTIBODY-COMBINING  SITES 
sufficiently  avid  anti-hapten  antibodies  should  be precipitated  equally  well 
by conjugates of the immunizing and heterologous carriers (providing they are 
sufficiently highly conjugated).  Thus  the different degrees of "carrier  specific- 
ity" demonstrated by the three sera (Figs. 6, 7~ may be explained equally well 
by heterogeneity of anti-BPO antibodies with regard  to avidity of binding  to 
the hapten,  as it can by heterogeneity of anti-BPO antibodies with regard to 
the dimensions of their combining sites (Cf. reference 1). 
Of interest is the data in Fig. 7 showing that DMPPO22-RSA prepared  under 
"denaturing" conditions precipitated considerably fewer antibodies from serum 
34 (rabbit anti-BPO4-RSA) than did DMPPO13-RSA and DMPPO18-RSA which 
were prepared under comparatively "mild" conditions as was the immunizing 
antigen,  BPO4-RSA.  Although  preliminary,  these  results  suggest  that  the 
method  of  preparation  of  a  hapten  conjugate  may  influence  its  ability  to 
precipitate anti-hapten  antibodies,  especially antibodies of low binding affinity 
for hapten.  The  results  suggest also that  anti-BPO  antibody-combining  sites 
may  be  adapted  to  secondary  and  tertiary  structural  configurations  of  the 
immunizing carrier protein. The finding that a mixture of DNP-lysyl peptides 
(prepared by pepsin digestion at pH 1-2 of the immunizing protein conjugate, 
DNP-BGG),  were  not  more  effective  than  was  e-DNP-lysine  in  dissolving 
anti-DNP precipitates  (26) might be due to the absence in the DNP-peptides 
of the specific secondary and  tertiary structural  configurations  against which 
the antibody is adapted. 
The  findings  presented  above  are  in  agreement  with  earlier  works  with 
smaller-sized  haptenic groups showing carrier specificity for anti-hapten  anti- 
bodies  (3-5),  and  are  consistent  also  with  more  recent  demonstrations  that 
human  anti-dextran  antibodies  (1)  and  rabbit anti-silk  fibroin antibodies  (2) 
are adapted to relatively large antigenic units. The present findings differ from 
those of Landsteiner and van der Scheer (6) who concluded that the combining 
sites  of  rabbit  antibodies  produced  against  the  SA  and  GIL  bifunctional 
haptens  (Fig.  1) were not sufficiently large  to encompass  the entire haptenic 
groups. Although these different results may reflect the differences between the 
chemical structures of the haptens used in the two studies, more work is neces- 
sary to clarify this apparent inconsistency. 
Although  it  is clear  that  anti-BPO  antibodies  demonstrate  specificity also 
for the protein carrier,  the size of the complementary area shared by antibody 
and  carrier  protein  is  unknown.  Accordingly  the  precise  dimensions  of  the ~ 
anti-BPO antibody-combining  sites could not be determined.  Nevertheless,  it 
is clear that at least a large part of the anti-BPO antibodies are complementary 
to an  antigenic  unit which is larger  than  the BPO group  (one steric form of 
which is 17/~ in length,  Fig.  1) (Cf. references 1, 2), and which comprises also 
the lysine side chain and other structural areas of the carrier protein. BERNARD B. LEVINE  181 
SUMMARY 
Rabbit antisera prepared against conjugates of the benzylpeniciUoyl (BPO) 
bifuncfional haptenic group were analyzed to determine whether the antibodies 
are  adapted  to only a  portion of the large BPO  molecule, or  to  the entire 
molecule, and whether specificity extends to the lysine side chain and adjoining 
structures of the immunizing carrier protein. 
No antibodies adapted to the phenylacetylamine portion of the BPO group 
could be detected in a pooled rabbit anti-BPO serum globulin fraction by PCA 
and quantitative precipitin analysis using several phenylacetylamine-protein 
conjugates as antigens. No antibodies adapted only to the thiazolidine carbox- 
ylic acid portion of the BPO molecule were detected in the anti-BPO globulin 
fraction using quantitative precipitin and hapten inhibition methods. At least 
the bulk of the anti-BPO antibodies was found to be adapted to the entire BPO 
haptenic group. 
By quantitative hapten inhibition of precipitation of the anti-BPO globulin 
fraction, the anti-BPO antibodies were found to show specificity for a 6 carbon 
amide side chain corresponding to the lysine side chain through which BPO 
groups are bound predominantly to protein. The contribution of this 6 carbon 
chain to antibody-hapten binding was small; (--AF  °) was calculated to be 460 
calories per mole (average). 
Rabbit anti-BPO  antibodies prepared  against BPO-rabbit  serum albumin 
conjugates showed specificity also toward structures of the immunizing carrier 
protein, and possibly toward secondary or tertiary structural configurations. 
Penicilloyl conjugates of rabbit serum albumin precipitated from 3 individual 
rabbit  antisera more anti-BPO antibodies than did penicilloyl conjugates of 
heterologous  carriers  (poly-L-lysine,  human  serum  albumin,  and  human 
"y-globulin). 
Anti-BPO antibodies demonstrated heterogeneity with regard to closeness 
of fit to the haptenic group, or with regard to the dimensions of the combining 
sites, or both. 
It was concluded that at least a large part of anti-BPO antibodies are specifi- 
cally adapted to a large antigenic unit comprised of the entire BPO group, the 
lysine  side  chain,  and  structural  configurations  of  the  immunizing  carrier 
protein. 
I thank Dr. B. Benacerraf for his helpful interest during this investigation.  These experi- 
ments were carried out with the competent technical  assistance of Miss. A. Sobel. 
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